
Sign up to save your podcasts
Or
Dr. Scott Gottlieb is the former commissioner of the Food and Drug Administration and resident fellow at the American Enterprise Institute, where he continues his work on improving public health through entrepreneurship and medical innovation and on expanding regulatory approaches to maintain patient and physician autonomy.
We talked about regulatory approaches to making prescription drugs more affordable. Learn why price controls, like those which would be implemented in the Democrats’ drug pricing bill HR3, have terrible consequences for the development and innovation of prescription drugs.
4.8
1600616,006 ratings
Dr. Scott Gottlieb is the former commissioner of the Food and Drug Administration and resident fellow at the American Enterprise Institute, where he continues his work on improving public health through entrepreneurship and medical innovation and on expanding regulatory approaches to maintain patient and physician autonomy.
We talked about regulatory approaches to making prescription drugs more affordable. Learn why price controls, like those which would be implemented in the Democrats’ drug pricing bill HR3, have terrible consequences for the development and innovation of prescription drugs.
6,872 Listeners
3,306 Listeners
22,747 Listeners
154,663 Listeners
14,300 Listeners
4,867 Listeners
2,844 Listeners
44,126 Listeners
6,597 Listeners
40,403 Listeners
6,180 Listeners
8,820 Listeners
26,668 Listeners
3,347 Listeners
1,052 Listeners